In this episode of The Talk, people living with HIV say it's important to honor your feelings, ask lots of questions, and ...

By Robbie Corey-Boulet and Ngouda Dione DAKAR, April 29 (Reuters) - Fewer patients are visiting some HIV treatment centres in ...

Indiana will end a statewide HIV outreach and testing program this summer after health officials say a drop in federal ...

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug ...

Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, research, and programs will jeopardize that progress. In the United States, ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

Zambia is facing a critical deadline to sign a minerals-tied aid agreement with the US or lose all remaining HIV funding, ...

Prism Health North Texas, a community health center, participated in clinical trials for Merck's new HIV treatment, Idvynso.

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

– Pivotal Phase 3 Findings Support the Potential of a Novel Single-Tablet Combination of Bictegravir and Lenacapavir for HIV Treatment – – Latest Data from the PURPOSE Program Further Demonstrates the ...

Participation in state AIDS Drug Assistance Programs was associated with improved HIV treatment outcomes and high rates of viral suppression.